Wells Fargo Maintains Overweight on Tenet Healthcare, Lowers Price Target to $213

Benzinga Newsdesk www.benzinga.com Negative 88.4%

Neg 88.4% Neu 0% Pos 0%

Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and lowers the price target from $265 to $213.